Cargando…

Surgical management of non-invasive uterine clear cell carcinoma

Detalles Bibliográficos
Autores principales:	Sugiyama, Toru, Takeuchi, Satoshi, Itamochi, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447153/ https://www.ncbi.nlm.nih.gov/pubmed/28541642 http://dx.doi.org/10.3802/jgo.2017.28.e55

Ejemplares similares

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
por: Takatori, Eriko, et al.
Publicado: (2014)

Sensitivity to Anticancer Agents and Resistance Mechanisms in Clear Cell Carcinoma of the Ovary
por: Itamochi, Hiroaki, et al.
Publicado: (2002)

Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study
por: Sarı, Mustafa Erkan, et al.
Publicado: (2017)

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
por: Shoji, Tadahiro, et al.
Publicado: (2012)

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
por: Shoji, Tadahiro, et al.
Publicado: (2021)

The future of (non-)surgical ablative therapy in uterine adenomyosis
por: De Wilde, R.L., et al.
Publicado: (2023)

Prognostic impact of lymphadenectomy in uterine clear cell carcinoma
por: Mahdi, Haider, et al.
Publicado: (2015)

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
por: Takano, Masashi, et al.
Publicado: (2012)

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
por: Mabuchi, Seiji, et al.
Publicado: (2016)

HIFU: Effects and Clinical Effectiveness of Non-surgical Therapy for Uterine Fibroids
por: Chang, Ikjin, et al.
Publicado: (2016)

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
por: Takano, M, et al.
Publicado: (2006)

Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target
por: Tsang, Tsun Yee, et al.
Publicado: (2017)

Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
por: Fukagawa, Daisuke, et al.
Publicado: (2018)

Uterine Clear Cell Carcinoma of Postmenopausal Woman: A Case Report
por: Chung, Soo-Ho, et al.
Publicado: (2016)

Clear cell carcinoma of the lower uterine segment: A case report
por: Matoba, Yusuke, et al.
Publicado: (2016)

Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix
por: Zong, Liju, et al.
Publicado: (2020)

Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C
por: Kolendowski, Bart, et al.
Publicado: (2020)

Complications of Uterine Fibroids and Their Management
por: Fletcher, Horace, et al.
Publicado: (2012)

Targeting Her2/neu in uterine serous carcinoma: A paradigm shift in management
por: Lopez, Salvatore, et al.
Publicado: (2018)

Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
por: Chow, Stephanie, et al.
Publicado: (2020)

Introduction to the Special Issue on “Keratinocyte Carcinomas: Biology and Evolving Non-Invasive Management Paradigms”
por: González, Salvador, et al.
Publicado: (2023)

Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma
por: Miyata, Kohei, et al.
Publicado: (2014)

Clear cell carcinoma of the uterine cervix: clinical characteristics and feasibility of fertility-preserving treatment
por: Jiang, Xiang, et al.
Publicado: (2014)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

Multi-omics approach reveals the secrets of metabolism of clear cell—renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2016)

Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes)
por: Manini, Claudia, et al.
Publicado: (2022)

Safety of fertility-sparing surgery for stage I ovarian clear cell carcinoma
por: Park, Jeong-Yeol
Publicado: (2017)

Renal cell carcinoma with non-clear cell histology or sarcomatoid differentiation: recent insight in an unmet clinical need
por: Donskov, Frede
Publicado: (2021)

Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies
por: Alldredge, Jill, et al.
Publicado: (2020)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
por: Salgia, Meghan, et al.
Publicado: (2017)

Non-surgical management of urinary incontinence in children
por: Duel, Barry
Publicado: (2009)

Invasive Micropapillary Carcinoma of the Uterine Cervix
por: Koh, Hyun Hee, et al.
Publicado: (2020)

Non–surgical management of abdominal ectopic pregnancy with uterine artery embolization
por: Ozen, Merve, et al.
Publicado: (2022)

Invasive clear-cell variant of squamous cell carcinoma mimicking sebaceous carcinoma()
por: Souza, Emilly Neves, et al.
Publicado: (2023)

Is It All Clear if Procalcitonin Clears in Acute Pancreatitis?
por: Kandasamy, Subramani
Publicado: (2020)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Clinical Significance of Atypical Glandular Cells in the Bethesda System 2001: A Comparison with the Histopathological Diagnosis of Surgically Resected Specimens
por: Shoji, Tadahiro, et al.
Publicado: (2014)

Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]
por: Takeuchi, Satoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_43arauc649oiahtc9ejmvv86a5